VANGL2 and breast cancer: In support of our findings, analysis of a publicly available dataset that accompanied the foundational study describing the contributions of K14-positive leader cells to breast cancer progression [6] determined that Wnt5a, Vangl1, and Vangl2 transcripts are significantly elevated in the K14-positive tumor cell population (Fig. 3c).